Promoters and FIIs increased stake: This small-cap pharma company targeted Rs 750 crore revenue!
Promoters and FIIs increased stake: This small-cap pharma company targeted Rs 750 crore revenue!

Promoters and FIIs increased stake: This small-cap pharma company targeted Rs 750 crore revenue!

The company plans to launch several new products in the domestic and export markets in Q3 and Q4 of FY24.

Aniket Gogate Article rating: 5.0

FII stake increase: Foreign Institutional Investors (FIIs) have increased their stake in Lincoln Pharma from 0.63 per cent in September 2022 to 2.59 per cent in September 2023.

Promoter holding increase: The promoter holding in Lincoln Pharma has also increased from 44.09 per cent in September 2022 to 50.53 per cent in September 2023.

This small-cap stock jumped 29 per cent in last two days, trades at 1.3 price-to-book value with improving net cash flow; watch out!
This small-cap stock jumped 29 per cent in last two days, trades at 1.3 price-to-book value with improving net cash flow; watch out!

This small-cap stock jumped 29 per cent in last two days, trades at 1.3 price-to-book value with improving net cash flow; watch out!

Interestingly, all these moving averages are in the desired sequence and in a rising trajectory

Karan Dsij Article rating: 4.4

The stock has registered a fresh 52-week high. Interestingly, the volume traded for the day was the highest ever seen, which was close to 17.8 lakh shares.   

RSS

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR